Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative 'idiopathic' erythrocytosis.

Spolverini A, Pieri L, Guglielmelli P, Pancrazzi A, Fanelli T, Paoli C, Bosi A, Nichele I, Ruggeri M, Vannucchi AM.

Haematologica. 2013 Sep;98(9):e101-2. doi: 10.3324/haematol.2013.090175. Epub 2013 Jun 28. No abstract available.

2.

Isolated erythrocytosis in V617F negative patients with JAK2 exon 12 mutations: report of a new mutation.

Bernardi M, Ruggeri M, Albiero E, Madeo D, Rodeghiero F.

Am J Hematol. 2009 Apr;84(4):258-60. doi: 10.1002/ajh.21357. No abstract available.

3.

LNK mutations in JAK2 mutation-negative erythrocytosis.

Lasho TL, Pardanani A, Tefferi A.

N Engl J Med. 2010 Sep 16;363(12):1189-90. doi: 10.1056/NEJMc1006966. No abstract available.

4.

The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels.

Percy MJ, Scott LM, Erber WN, Harrison CN, Reilly JT, Jones FG, Green AR, McMullin MF.

Haematologica. 2007 Dec;92(12):1607-14.

5.

Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis.

Williams DM, Kim AH, Rogers O, Spivak JL, Moliterno AR.

Exp Hematol. 2007 Nov;35(11):1641-6. Epub 2007 Oct 17.

6.

Molecular study of congenital erythrocytosis in 70 unrelated patients revealed a potential causal mutation in less than half of the cases (Where is/are the missing gene(s)?).

Bento C, Almeida H, Maia TM, Relvas L, Oliveira AC, Rossi C, Girodon F, Fernandez-Lago C, Aguado-Diaz A, Fraga C, Costa RM, Araújo AL, Silva J, Vitória H, Miguel N, Silveira MP, Martin-Nuñez G, Ribeiro ML.

Eur J Haematol. 2013 Oct;91(4):361-8. doi: 10.1111/ejh.12170. Epub 2013 Aug 20.

PMID:
23859443
7.

Serum levels of granulocyte colony-stimulating factor in JAK2 V617F-positive vs. negative erythrocytosis.

Fujita H, Hamaki T, Ohwada A, Tomiyama J, Nishimura S.

Int J Lab Hematol. 2011 Dec;33(6):e20-1. doi: 10.1111/j.1751-553X.2011.01336.x. Epub 2011 Jun 6. No abstract available.

PMID:
21645282
8.

JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis.

Martínez-Avilés L, Besses C, Alvarez-Larrán A, Cervantes F, Hernández-Boluda JC, Bellosillo B.

Haematologica. 2007 Dec;92(12):1717-8.

9.

LNK mutations and myeloproliferative disorders.

McMullin MF, Cario H.

Am J Hematol. 2016 Feb;91(2):248-51. doi: 10.1002/ajh.24259. Review.

PMID:
26660394
10.

The complete evaluation of erythrocytosis: congenital and acquired.

Patnaik MM, Tefferi A.

Leukemia. 2009 May;23(5):834-44. doi: 10.1038/leu.2009.54. Epub 2009 Mar 19. Review.

PMID:
19295544
11.

LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations.

Pardanani A, Lasho T, Finke C, Oh ST, Gotlib J, Tefferi A.

Leukemia. 2010 Oct;24(10):1713-8. doi: 10.1038/leu.2010.163. Epub 2010 Aug 19.

PMID:
20724988
12.

A nonsynonymous LNK polymorphism associated with idiopathic erythrocytosis.

McMullin MF, Wu C, Percy MJ, Tong W.

Am J Hematol. 2011 Nov;86(11):962-4. doi: 10.1002/ajh.22154. Epub 2011 Aug 22. No abstract available.

13.

Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera.

Rossi D, Cortini F, Deambrogi C, Barbieri C, Cerri M, Franceschetti S, Conconi A, Capello D, Gaidano G.

Leuk Res. 2007 Jan;31(1):97-101. Epub 2006 Apr 18.

PMID:
16620973
14.

Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera.

Schnittger S, Bacher U, Haferlach C, Geer T, Müller P, Mittermüller J, Petrides P, Schlag R, Sandner R, Selbach J, Slawik HR, Tessen HW, Wehmeyer J, Kern W, Haferlach T.

Haematologica. 2009 Mar;94(3):414-8. doi: 10.3324/haematol.13223.

15.

Loss of the JAK2 intramolecular auto-inhibition mechanism is predicted by structural modelling of a novel exon 12 insertion mutation in a case of idiopathic erythrocytosis.

Albiero E, Madeo D, Ruggeri M, Bernardi M, Giorgetti A, Rodeghiero F.

Br J Haematol. 2008 Sep;142(6):986-90. doi: 10.1111/j.1365-2141.2008.07180.x. Epub 2008 Jul 30.

PMID:
18671703
16.

JAK2 V617F mutation is rare in idiopathic erythrocytosis: a difference from polycythemia vera.

Yoshinaga K, Mori N, Wang YH, Tomita K, Shiseki M, Motoji T.

Int J Hematol. 2008 Jul;88(1):82-7. doi: 10.1007/s12185-008-0103-6. Epub 2008 Jun 6.

PMID:
18528646
17.

The incidence of the JAK2 V617F mutation in patients with idiopathic erythrocytosis.

Percy MJ, Jones FG, Green AR, Reilly JT, McMullin MF.

Haematologica. 2006 Mar;91(3):413-4. Epub 2006 Feb 17.

18.

Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.

Tong W, Zhang J, Lodish HF.

Blood. 2005 Jun 15;105(12):4604-12. Epub 2005 Feb 10.

19.

Fast and reliable mutation detection of the complete exon 11-15 JAK2 coding region using non-isotopic RNase cleavage assay (NIRCA).

Kambas K, Mitroulis I, Kourtzelis I, Chrysanthopoulou A, Speletas M, Ritis K.

Eur J Haematol. 2009 Sep;83(3):215-9. doi: 10.1111/j.1600-0609.2009.01279.x. Epub 2009 Jun 2.

PMID:
19500139
20.

Isolated erythrocythemia: a distinct entity or a sub-type of polycythemia vera?

Ohyashiki K, Kiguchi T, Ito Y, Gotoh A, Tauchi T, Miyazawa K, Kimura Y, Hisatomi H, Ohyashiki JH.

Jpn J Clin Oncol. 2008 Mar;38(3):230-2. doi: 10.1093/jjco/hym174. Epub 2008 Feb 21. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk